Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia & Company Psychedelics Investing
COMPASS Pathways announces publication of first study evaluating potential of AI model to predict outcomes of COMP360 psilocybin treatment in treatment-resistant depression Psychedelics Investing
Silo Wellness Announces LOI to Acquire NUGL/Kaya in a Transaction Valued at CAD $43,289,624.60; CSE to Halt Trading Until Shareholder Approval Psychedelics Investing
Melodiol Subsidiary Mernova Medicinal Inc. Scales Up As Q3 Sales Momentum Accelerates Cannabis Investing News
COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthcare Investors Psychedelics Investing
Goodness Growth Holdings Expands Maryland Retail Presence Through Consulting, Licensing and Wholesale Agreements with Two Additional Dispensaries Psychedelics Investing
